Yizhi capsule for vascular dementia

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages 259-

  Wu, Taixiang ^a   Li, Q P ^b   Yuan, Z Y ^b  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

Capsules; Dementia, vascular *drug therapy ; Drugs, Chinese herbal *therapeutic use ; Humans; Phytotherapy *methods

Indexed keywords

RETRACTED ARTICLE; REVIEW;

EID: 45249107305     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005382.pub2     Document Type: Review

References (43)

1. Chen 1997 Chen K, Chen KJ, Zhou WQ, Chui N, Tu RS, Gao P etc. Yizhi Capsule in the treatment of senile vascular dementia, a randomized trial [Clinical Study of Effect of Yizhi Capsule on Senile Vascular denentia]. Chinese Journal of Integrated traditional Chinese and Western Medicine 1997;17(7):393-7.
2. Qiao 2004 Qiao QZ, Zhang ZQ, Liu HR, Chang ZY. Effect of fushen yizhi capsule on the blood lipid and hemorheology in elderly patients with vascular dementia. Chinese Journal of Clinical Rehabilitation 2004;8 (31):6962-3.
3. Wang 2000 Wang XF, Wang KP, Wang FJ. Yizhi Zaizao capsule in the treatment of vascular dementia with 50 cases.Modern Journal of Integrated Traditional Chinese and Western Medicine 2000;9(14):1373-4.
4. Wang 2002 Wang FJ, Lu SJ, Dong Z. Yizhi TOngluo capsule in the treatment of vascular dementia. Modern Journal of Integrated Tradtional Chinese and Western Medicine 2002;11(4):295-7.
5. Yan 2001 Yan XP, Wang H, Zhang TZ. Clinical observation on effect of Tongmai Yizhi capsule in treating vascular dementia. Chinese Journal of Integrated Tradetional Chinese and Western Medicine 2001;21(8):573-5.
6. Zhang 2004 Ji LJ, Zhang MZ. Qiangpi Bujin Huayu. Yizhi capsule in the treatment of multi-infarct dementia. Journal of Fujian College of TCM 2004;14(1):1-3.
7. Ji LJ, Zhang MZ. Qiangpi Bujin Huayu. Yizhi capsule in the treatment of multi-infarct dementia. Journal of Fujian College of TCM 2004;14(4):1-3.
8. Ji LJ, Zhang MZ. Qiangpi Bujin Huayu. Yizhi capsule in the treatment of multi-infarct dementia. Journal of Fujian College of TCM 2004;14(5):1-3.
9. Zhang MZ, Dong ZX, Mao YJ, Du F. A randomised controlled trial of Yizhi capsule in the treatment ofmulti-infarct dementia [Effects of Yi-zhi capsule on multi-infarct dementia and intelligence quotient]. Medical Journal of Qilu 2004;19(1):31-2.
10. Zhang MZ, Dong ZX, Mao YJ, Du F. Effect of yizhi capsule on the intelligence of patient with multi-infarct dementia. Chinese Journal of Clinical Rehabilitation 2005;9(36):155-7.
11. Aevarsson 1998 Aevarsson O, Svanborg A, Skoog I. Seven-year survival after age 85 years. Relation to Alzheimer disease and vascular dementia. Arch Neurol 1998 1998;55:1226-32.
12. APA 1997 American Psychiatric Association, APA. Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. Am J Psychiatry 1997;154(5 suppl):1-39.
13. APA 2000 American Psychiatric Association, APA. DSM-IV criteria for the diagnosis of vascular dementia. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders 2000.
14. Atkins 1993 Atkins D, Psaty BM, Koepsell TD, et al.Cholesterol reduction and the risk for stroke in men: a meta-analysis of randomized controlled trials. Ann Intern Med 1993;119:136-45.
15. Chen 1998 Chen JC, Min Y, Wang GQ, Wang Y, Ji JM, Zhang Y. Comparing the effect of anti platelet aggregation of Nao An capsule to aspirin. Chinese Journal of Clinical Pharmaology 1998;7(3):144-5.
16. Chen 1999 Chen KJ. Ligustrazine's chemical and pharmacological property and clinical application. Ligustrazine's chemical and pharmacological property and clinical application. 1. Beijing: People's Health Publication House, 1999.
17. Fulder 1996 Fulder S. The Handbook of Alternative and Complementary Medicine. Oxford: Oxford University, 1996.
18. Gorelick 1993 Gorelick PB, Brody JA, Cohen DC, et al.Risk factors for dementia associated with multiple cerebral infarcts: a case-control analysis in predominantly African-American hospital-based patients. Arch Neurol 1993;28:724-29.
19. Hebert 1995 Hebert R, Brayne C. Epidemiology of vascular dementia. Neuroepidemiology 1995;14(5):240-57.
20. Ikeda 2001 Ikeda M, Hokoishi K, Maki, et al.Increased prevalence of vascular dementia in Japan: A community-based epidemiological study. Neurology 2001;84(5):461-7.
21. Jorm 1998 Jorm AF, Jolley D. The incidence of dementia: a meta-analysis. Neurology 1998;51:738-33.
22. Kalmijn 1997 Kalmijn S, Launer LJ, Ott A. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Annals ofNeurology 1997;42(5):137-44.
23. Kannayiram 2004 Kannayiram Alagiakrishnan, Kamal Masaki. Vascular Dementia. http://www.emedicine.com/med/topic3150.htm. 2004.
24. Kuller 2005 Kuller LH, Lopez OL, Jagust WJ, Becker JT, DeKosky ST, Lyketsos C, Kawas C, Breitner JC, Fitzpatrick A, Dulberg C. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology 2005;64(9):1548-52.
25. Lawrence 1996 Lawrence M, Cruickshank K. Hypertension. Prevention of Cardiovascular Disease. Lawrence M, Neil A, Mant D, Fowler G. Oxford: Oxford University, 1996.
26. Li 2004 Li AH, Ke KF, Wu XM, Bao SR. Effects of GSRb1, Rb3, Rg1 against ischemic injury of cultured cortical neurons and its mechanism. Journal of Stroke and Neurology 2004;21(3):231-3.
27. Liu 2003 Liu L, Guo XE, Zhou YQ, Xia JL. Prevalence of dementia in China. Dement Geriatr Cogn Disord 2003;15(4):226-30.
28. McKhann 1994 McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1994;34:939-944.
29. Mo 2004 Mo SH, Yang YY, Liu N, Li J, Ling ZJ, Xie JP. Effect of Herba Epimedii on the visceral organs in rats by 45Ca transmembrane flow technique. Journal of Chinese Traditional Medicine 2004;2(4):196- 9.
30. Olin 2000 J Olin, L Schneider, A Novit, S Luczak. Hydergine for dementia. Cochrane Database of Systematic Reviews 2000, Issue 3.Art. No.: CD000359. DOI:10.1002/14651858.CD000359.
31. Ou 1987 Ou XC, Ding JX, Zhang N. Experimental survey of 126 Chinese Medicine antithrombin function. Chinese Traditional and Herbal Drags 1987;18(4):21.
32. Pohjasvaara 1998 Pohjasvaara T, Erkinjuntti T, Ylikoski R, et al.Clinical determinants of poststroke dementia. Stroke 1998;29:75-81.
33. Ravaglia 2005 Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Dalmonte E, Bianchin M, Mariani E. Incidence and etiology of dementia in a large elderly Italian population. Neurology 2005;64(9):1525-30.
34. Roman 2003 Roman GC. Vascular dementia: distinguishing characteristics, treatment, and prevention. Journal of the American Geriatrics Society 2003 2003;51(5 Suppl Dementia):S296-304.
35. Schneider 1994 Schneider LS, Olin JT. Overview of clinical trials of hydergine in dementia. Archives of Neurology 1994;51(8):787-98.
36. Skoog 1994 Skoog I. Rick factors for vascular dementia: A review.Dementia 1994; 5:137-44.
37. Skoog 1998 Skoog I. Status of risk factors for vascular dementia. Neuroepidemiology 1998;17(1):2-9.
38. Sun 2004 Sun QX, Hu YE, Guan H, Xia ZQ. Effects of ZDY101, an active component from Zhimu, on rat dementia model produced by intracranial injection of ibotenic acid. Nuclear Techniques 2004;27(4):297-300.
39. Takehiko 2002 Takehiko Y. Vascular Dementia in Japan. Annals of the New York Academy of Sciences 2002;977:24-8.
40. Tarja 1998 Tarja Pohjasvaara, Timo Erkinjuntti, R. Ylikoski, M. Hietanen, Risto Vataja, Markku Kaste. Clinical Determinants of Poststroke Dementia. Stroke 1998;29:75-81.
41. Wei 2004 Wei PF, Jiao CL, Chen DD. Heshouwu's pharmacological research. Modern Traditional Chinese Medicine 2004;1:57-8.
42. WHO 1992 World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical description and diagnostic guidelines. Geneva: World Health Organisation, Division of Mental Health, 1992.
43. Williams 2003 Williams PS, Rands G, Orrel M. Spector A. Aspirin for vascular dementia. The Cochrane Library 2003, issue 3.